Incannex Healthcare Income Statement (2020-2026) | IXHL

Income Statement Jun2020 Jun2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.07M0.01M
Operating items
Research & Development (Quarter) 1.55M1.64M1.71M2.61M2.64M3.28M4.36M2.90M1.41M2.73M3.70M1.12M2.28M0.32M
Selling, General & Administrative (Quarter) 2.09M2.01M2.48M2.28M5.34M4.14M5.40M3.43M3.60M2.27M3.83M5.67M4.71M3.73M
Other Operating Expenses (Quarter) -1.09M
Operating Expenses (Quarter) 3.64M3.65M4.19M4.89M7.98M7.42M9.76M6.33M5.02M5.00M7.53M6.79M7.00M4.05M
Operating Income (Quarter) -3.64M-3.65M-4.19M-4.89M-7.98M-7.42M-9.74M-6.25M-5.00M-5.00M-7.53M-6.79M-7.00M-4.05M
EBIT (Quarter) -3.64M-3.65M-4.19M-4.89M-7.98M-7.42M-9.74M-6.25M-5.00M-5.00M-7.53M-6.79M-7.00M-4.05M
Non-operating items
Interest & Investment Income (Quarter) 0.06M0.16M0.09M0.07M0.02M0.07M0.04M0.03M0.03M0.00M0.00M0.01M
Other Non Operating Income (Quarter) -0.00M-0.01M-0.01M-0.01M-0.01M-0.33M0.04M0.70M-0.01M-0.02M0.03M
Non Operating Income (Quarter) 0.72M0.08M0.02M4.17M2.74M1.38M3.31M0.83M-0.89M1.03M-24.07M0.39M0.47M0.17M
Net income details
EBT (Quarter) -2.92M-3.57M-4.17M-0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Profit After Tax (Quarter) -2.92M-3.57M-7.75M-0.73M-5.24M-6.03M-6.46M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Equity Income (Quarter) 0.01M0.01M-0.04M
Income from Continuing Operations (Quarter) -2.92M-3.57M-4.17M-0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Consolidated Net Income (Quarter) -2.92M-3.57M-4.17M-0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Income towards Parent Company (Quarter) -2.92M-3.57M-4.17M-0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Net Income towards Common Stockholders (Quarter) -2.92M-3.57M-4.17M-0.73M-5.24M-6.03M-6.43M-5.42M-5.89M-3.97M-31.60M-6.41M-6.52M-3.88M
Additional items
EPS (Basic) (Quarter) 0.05-0.22-0.27-0.08-0.33-0.38-0.39-0.29-0.33-6.1924.04-0.02-0.02-0.35
EPS (Weighted Average and Diluted) (Quarter) -0.20-0.22-0.27-0.08-0.33-0.38-0.39-0.29-0.33-6.1924.04-0.02-0.02-0.35
Shares Outstanding (Weighted Average) (Quarter) 5.75M10.00M1,191.15M14.90M15.22M15.38M15.87M15.87M15.87M16.16M17.64M17.56M0.65M34.45M310.31M349.46M12.35M
Shares Outstanding (Diluted Average) (Quarter) 14.90M15.87M15.38M15.87M15.87M15.87M16.16M17.64M17.56M0.61M34.45M310.31M349.46M12.35M
EBITDA (Quarter) 0.77M-3.77M-4.19M-1.24M-4.31M-6.85M-6.13M-5.08M-6.31M-4.06M-31.28M-6.20M-6.81M-4.35M
Interest Expenses (Quarter) -0.03M-0.03M0.13M-0.01M-0.01M
Shares Outstanding (Quarter) 12.93M15.87M15.87M15.87M15.87M15.87M15.87M0.59M0.59M0.59M0.92M6.48M11.59M11.97M13.68M